![Paul West](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Paul West is a successful entrepreneur and an experienced hands-on investor in companies in various industries.
His area of expertise is on the strategic marketing and sales side and Mr. West actively fosters rapid growth of these companies by capitalising on his extensive business network.
In 1979, Mr. West acquired West Instruments and transformed the company into a leading, well-positioned value added reseller of orthopaedic and traumatologic products.
Prior to this, Mr. West held several marketing and sales positions in the Netherlands with leading international companies such as Sara Lee and Hoechst.
Mr. West has acted as a business angel since 1998 and joined VenGen as Venture Partner in 2005.
Anciens postes connus de Paul West
| Sociétés | Poste | Fin |
|---|---|---|
VenGen BV
 VenGen BV Investment ManagersFinance VenGen's investment strategy focuses on pre-seed stage ventures. They look for technologies that represent significant breakthroughs primarily in life sciences in addition to therapeutics, diagnostics, medical devices and platform technologies. They also consider ideas that have initial proof of concept such as validation via publication in peer-reviewed journals, protection through patent applications or awards of competitive grants. Among VenGen's other investment criteria are technologies or products with substantial market value which meet an unmet need and personal fit between the entrepreneur and the firm's founders. The firm provides various levels of funding. When the business concept, intellectual property, scientific basis and market potential are deemed promising, they provide an investment of EUR 10 thousand combined with entrepreneurial coaching (VenGen Support). Another stage of investment is when the business plan is defined, the spin-out process finalized and investors have been identified. At this point, VenGen invests up to EUR 50 thousand (VenGen Accell). VenGen is an active, hands-on partner. They provide business expertise and management experience in addition to initial funding. They are committed to their portfolio firm's by playing an active role. They draw on their wide network of specialized business and industry partners for the benefit of the entrepreneurs. They organize meetings with their advisory board members to discuss strategic developments and planning. VenGen also considers spin-out opportunities which are directly initiated by technology transfer officials associated with research departments of universities and life science institutes. | Private Equity Investor | 31/12/2015 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
VenGen BV
VenGen BV Investment ManagersFinance VenGen's investment strategy focuses on pre-seed stage ventures. They look for technologies that represent significant breakthroughs primarily in life sciences in addition to therapeutics, diagnostics, medical devices and platform technologies. They also consider ideas that have initial proof of concept such as validation via publication in peer-reviewed journals, protection through patent applications or awards of competitive grants. Among VenGen's other investment criteria are technologies or products with substantial market value which meet an unmet need and personal fit between the entrepreneur and the firm's founders. The firm provides various levels of funding. When the business concept, intellectual property, scientific basis and market potential are deemed promising, they provide an investment of EUR 10 thousand combined with entrepreneurial coaching (VenGen Support). Another stage of investment is when the business plan is defined, the spin-out process finalized and investors have been identified. At this point, VenGen invests up to EUR 50 thousand (VenGen Accell). VenGen is an active, hands-on partner. They provide business expertise and management experience in addition to initial funding. They are committed to their portfolio firm's by playing an active role. They draw on their wide network of specialized business and industry partners for the benefit of the entrepreneurs. They organize meetings with their advisory board members to discuss strategic developments and planning. VenGen also considers spin-out opportunities which are directly initiated by technology transfer officials associated with research departments of universities and life science institutes. | Finance |
